Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Elomaa

Showing results (81-90 of 143) with videos related to

Pageof 15
Sort By:
Scandinavian Journal of Gastroenterology|May 1, 1987
Screening for colorectal carcinoma in cancer family syndrome kindredsJ P Mecklin, H J Järvinen, S Aukee, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Monitoring the action of clodronate with type I collagen metabolites in multiple myelomaI Elomaa, L Risteli, M Laakso, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1995
The prognosis of stage III breast cancer treated with postoperative radiotherapy and adriamycin-based chemotherapy with and without tamoxifen. Eight year follow-up results of a randomized trialT Saarto, C Blomqvist, K Tiusanen, et al.
Bone|January 1, 1988
Evaluation of salmon calcitonin treatment in bone metastases from breast cancer--a controlled trialC Blomqvist, I Elomaa, L Porkka, et al.
European Urology|January 1, 1988
Aminoglutethimide for advanced prostatic cancer resistant to conventional hormonal therapyI Elomaa, T Taube, C Blomqvist, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2001
Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatmentL Vehmanen, T Saarto, I Elomaa, et al.
British Journal of Cancer|May 1, 1996
Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinomaC Blomqvist, L Risteli, J Risteli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
Influence of treatment schedule on toxicity and efficacy of cyclophosphamide, epirubicin, and fluorouracil in metastatic breast cancer: a randomized trial comparing weekly and every-4-week administrationC Blomqvist, I Elomaa, P Rissanen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The effect of clodronate on bone in metastatic prostate cancer. Histomorphometric report of a double-blind randomised placebo-controlled studyT Taube, T Kylmälä, C Lamberg-Allardt, et al.
Bone|March 1, 1994
Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancerT Taube, I Elomaa, C Blomqvist, et al.
Pageof 15

Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
Scandinavian Journal of Gastroenterology|May 1, 1987
Screening for colorectal carcinoma in cancer family syndrome kindredsJ P Mecklin, H J Järvinen, S Aukee, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Monitoring the action of clodronate with type I collagen metabolites in multiple myelomaI Elomaa, L Risteli, M Laakso, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1995
The prognosis of stage III breast cancer treated with postoperative radiotherapy and adriamycin-based chemotherapy with and without tamoxifen. Eight year follow-up results of a randomized trialT Saarto, C Blomqvist, K Tiusanen, et al.
Bone|January 1, 1988
Evaluation of salmon calcitonin treatment in bone metastases from breast cancer--a controlled trialC Blomqvist, I Elomaa, L Porkka, et al.
European Urology|January 1, 1988
Aminoglutethimide for advanced prostatic cancer resistant to conventional hormonal therapyI Elomaa, T Taube, C Blomqvist, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2001
Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatmentL Vehmanen, T Saarto, I Elomaa, et al.
British Journal of Cancer|May 1, 1996
Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinomaC Blomqvist, L Risteli, J Risteli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
Influence of treatment schedule on toxicity and efficacy of cyclophosphamide, epirubicin, and fluorouracil in metastatic breast cancer: a randomized trial comparing weekly and every-4-week administrationC Blomqvist, I Elomaa, P Rissanen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The effect of clodronate on bone in metastatic prostate cancer. Histomorphometric report of a double-blind randomised placebo-controlled studyT Taube, T Kylmälä, C Lamberg-Allardt, et al.
Bone|March 1, 1994
Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancerT Taube, I Elomaa, C Blomqvist, et al.
Pageof 15